Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) – 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS-3028 Category:

OVERVIEW

Amid the COVID-19 pandemic, the global market for nasal drug delivery technology is expected to grow over the forecast period at a CAGR of 5.9%. Growing patient preference for the delivery of nasal drugs as a result of easy administration & enhanced efficacy and rising acceptance of self-administration practices are some of the major factors driving growth in the demand for nasal drug delivery technologies. The report will also account for COVID-19 as a key market contributor.

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 1

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 2

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 3

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 4

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 5

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 6

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 7

Nasal Drug Delivery Technology Market by Therapeutic Applications (Congestion, Rhinitis, Vaccinations), Dosage Form (Sprays, Powder, Nasal Drops, Gel), System (Unit Dose, Multidose, BI-Dose), End User (Homecare, Hospitals) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Nasal Drug Delivery Technology Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Nasal Drug Delivery Technology Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Nasal Drug Delivery Technology Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Nasal Drug Delivery Technology Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Nasal Drug Delivery Technology Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Nasal Drug Delivery Technology Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Nasal Drug Delivery Technology Market – By Dosage Form (Market Size – &
million/billion)
8.1 Sprays
8.2 Drops & Liquids
8.3 Powders
8.4 Gels

9 Global Nasal Drug Delivery Technology Market – By Container
9.1 Pressurized Containers
9.2 Non-pressurized Containers

10 Global Nasal Drug Delivery Technology Market – By System
10.1 Multi-dose Systems
10.2 Bi-dose Systems
10.3 Unit-dose Systems

11 Global Nasal Drug Delivery Technology Market – By Therapeutic Application
11.1 Allergic And Non-allergic Rhinitis
11.2 Nose Congestion
11.3 Vaccination
11.4 Other

12 Global Nasal Drug Delivery Technology Market – By End-User
12.1 Home Care Settings
12.2 Hospitals

13 Global Nasal Drug Delivery Technology Market – By Geography (Market Size – &
million/billion)
13.1 Introduction
13.2 North America
13.2.1 US
13.2.2 Canada
13.2.3 Mexico
13.3 Europe
13.3.1 U.K
13.3.2 Germany
13.3.3 Italy
13.3.4 France
13.3.5 Spain
13.3.6 Rest of Europe
13.4 Asia-Pacific
13.4.1 China
13.4.2 Japan
13.4.3 India
13.4.4 South Korea
13.4.5 Rest of APAC
13.5 Rest of the World
13.5.1 South America
13.5.2 Middle East
13.5.3 Africa

14 Global Nasal Drug Delivery Technology Market – Entropy
14.1 New product launches
14.2 M&A’s, collaborations, JVs and partnerships

15 Global Nasal Drug Delivery Technology Market Company Profile (Key Players)
15.1 Market Share, Company Revenue, Products, M&A, Developments
15.2 Merck & Co., Inc.
15.3 Novartis AG
15.4 Aegis Therapeutics LLC
15.5 3M
15.6 Becton, Dickinson and Company
15.7 Glaxosmithkline PLC
15.8 Johnson & Johnson Services, Inc.
15.9 Pfizer Inc.
15.10 Astrazeneca PLC
15.11 Aptargroup, Inc.
15.12 Company 11 & more

16 Global Nasal Drug Delivery Technology Market – Appendix
16.1 Sources
16.2 Abbreviations